Kaytex Fabrics shares list 20% lower than the IPO price at ₹144 on the NSE SME: Listing much below expectation
Kaytex Fabrics share price, after seeing a weak debut listing at 20% discount to the upper band of the issue price of ₹ 180, at ₹ 144 , traded weak thereafter.
The Kaytex Fabrics share price oscillated between high of ₹ 151.20 and low of ₹ 136.80 on the the NSE SME on Tuesday.
The Kaytex Fabrics IPO had seen a strong response. The Kaytex Fabrics IPO was subscribed 42.70 times. By July 31, 2025, the public offering had been subscribed for 47.85 times by individual investors, 31.16 times by QIB, and 43.19 times by NII.
The listing of Kaytex Fabrics shares was below investor expectations, as indicated by the grey market premium.
The Kaytex Fabrics IPO GMP, or the Grey Market Premium, stood at +15. This means that Kaytex Fabrics shares were selling in the grey market with an ₹ 15 premium over the issue price's upper range of ₹ 180, as indicated by data from InvestorGain.com.
This meant that the investors anticipated Kaytex Fabrics shares to be listed with an 8.33% premium, above the upper range of the offering price of ₹ 180 and at the ₹ 195 level. Clearly the actual listing of Kaytex Fabrics shares was much below expectations.
Kaytex Fabrics Limited is a fast-fashion producer that was founded in January 1996 and produces high-quality textiles by fusing technology, innovative design, and workmanship. It specializes in textiles made from a variety of fibers, including polyester, viscose, and cotton.
The company sells women's ready-to-stitch clothing, high-quality materials, and contemporary, stylish designs. It provides bulk purchasers and merchants without specific branding with high-quality fabrics, clothing like ready-to-stitch suits, and accessories like stoles, scarves, and shawls.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
12 hours ago
- Economic Times
SME IPO: Medistep Healthcare's Rs 16-cr public issue to open on Aug 8
Pharmaceutical firm Medistep Healthcare is set to raise a little over Rs 16 crore through its initial public offering (IPO), which opens for subscription on August 8. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Pharmaceutical firm Medistep Healthcare is set to raise a little over Rs 16 crore through its initial public offering ( IPO ), which opens for subscription on August company's maiden public issue will conclude on August 12. The shares are scheduled to be listed on the NSE SME platform on August 18, Medistep Healthcare said in a IPO comprises 37.44 lakh equity shares priced at a fixed Rs 43 per share, aggregating to a total issue size of Rs 16.09 crore. Following the listing, the company is expected to have a market capitalisation of Rs 61.10 company will utilise the proceeds of the IPO for purchase of plant and machinery for expansion of its existing manufacturing facility, working capital requirements and general corporate purposes."Proceeds from the IPO will strategically support our expansion efforts and reinforce our footprint in both domestic and international markets," Girdhari Lal Prajapati, Managing Director at Medistep Healthcare, company is in the business of manufacturing sanitary pads & energy powder, and trading of a diverse range of pharmaceutical products, nutraceutical products, intimate products and surgical products through a distribution the financial front, the company recorded revenue from operations of Rs 49.65 crore in FY25, an increase from Rs 39.07 crore in the preceding fiscal. Its profit after tax (PAT) also rose to Rs 4.14 crore in FY25, compared to Rs 3.33 crore in the previous financial Track Finsec is the sole lead manager of the public issue while Cameo Corporate Services is the registrar to the issue.
Time of India
12 hours ago
- Time of India
SME IPO: Medistep Healthcare's Rs 16-cr public issue to open on Aug 8
Pharmaceutical firm Medistep Healthcare is set to raise a little over Rs 16 crore through its initial public offering ( IPO ), which opens for subscription on August 8. The company's maiden public issue will conclude on August 12. The shares are scheduled to be listed on the NSE SME platform on August 18, Medistep Healthcare said in a statement. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program The IPO comprises 37.44 lakh equity shares priced at a fixed Rs 43 per share, aggregating to a total issue size of Rs 16.09 crore. Following the listing, the company is expected to have a market capitalisation of Rs 61.10 crore. The company will utilise the proceeds of the IPO for purchase of plant and machinery for expansion of its existing manufacturing facility, working capital requirements and general corporate purposes. "Proceeds from the IPO will strategically support our expansion efforts and reinforce our footprint in both domestic and international markets," Girdhari Lal Prajapati, Managing Director at Medistep Healthcare, said. Live Events The company is in the business of manufacturing sanitary pads & energy powder, and trading of a diverse range of pharmaceutical products, nutraceutical products, intimate products and surgical products through a distribution network. On the financial front, the company recorded revenue from operations of Rs 49.65 crore in FY25, an increase from Rs 39.07 crore in the preceding fiscal. Its profit after tax (PAT) also rose to Rs 4.14 crore in FY25, compared to Rs 3.33 crore in the previous financial year. Fast Track Finsec is the sole lead manager of the public issue while Cameo Corporate Services is the registrar to the issue.
Business Standard
19 hours ago
- Business Standard
NSE SME Kaytex Fabrics threads a rough debut
Shares of Kaytex Fabrics was trading at Rs 147 on the NSE, a discount of 18.33% compared with the issue price of Rs 180. The scrip was listed at Rs 144, a discount of 20% compared with the initial public offer (IPO) price. The stock is currently up 2.08% over its listing price. The counter hit a high of Rs 151.20 and a low of Rs 136.80. About 10.37 lakh shares of the company changed hands at the counter. Kaytex Fabrics' IPO was subscribed 39.95 times. The issue opened for bidding on 29 July 2025 and it closed on 31 July 2025. The price band of the IPO was set at Rs 171 to Rs 180 per share. The IPO comprised 38,78,400 equity shares, including a fresh issue of 31,99,200 equity shares and offer for sale (OFS) of 6,79,200 equity shares. The company intends to utilize the net proceeds for funding capital expenditure for the construction of an additional warehouse facility in Amritsar, the construction of a dedicated sales office in Amritsar, and the purchase of an advanced fabric processing system for its existing printing, dyeing, and processing unit in Amritsar. Additionally, the proceeds will be used to meet incremental working capital requirements and for general corporate purposes. Ahead of the Kaytex Fabrics on 28 July 2025, raised Rs 16.79 crore from anchor investors. The board has allotted 9.32 lakh shares at Rs 180 per share to 11 anchor investors. Kaytex Fabrics is a fast-fashion fabric solutions and manufacturing enterprise. It specializes in producing fabrics from fibres such as cotton, viscose, and polyester, with a strong focus on digital printing technology. Expanding into womenswear, it also offers a diverse range of ready-to-stitch suits, co-ord sets, shawls, and stoles. As of 30 June 2025, the company had 612 permanent employees and workers. The company recorded revenue from operations of Rs 152.79 crore and net profit of Rs 16.90 crore for the period ended 31 March 2025.
